U.S., Feb. 4 -- ClinicalTrials.gov registry received information related to the study (NCT06804148) titled 'MYVAL Transcatheter Heart Valve System - Prospective German Multicenter Registry' on Jan. 27.
Brief Summary: Rational of the Myval THV - Prospective German Multicenter Registry is to evaluate the performance of this relatively new but very promising TAVR valve in a consecutive real-word, all-comers registry and to assess the long-term durability and efficacy of the Myval THV.
Study Start Date: Jan. 01
Study Type: OBSERVATIONAL
Condition:
Aortic Valve Stenosis
Intervention:
DEVICE: Myval Transcatheter Heart Valve
The Myval TAVR bioprothesis is a balloon-expandable THV developed by Meril Lifesciences, which has novel operator fr...